Evidence map›Paper›PMID 6088661›Full record

ArticleThe Journal of experimental medicine1984

Voltage-gated potassium channels are required for human T lymphocyte activation.

K G Chandy, T E DeCoursey, M D Cahalan, C McLaughlin, S Gupta

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 1984. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 107 papers.

0numbers the graph read from it
0cells of the map it votes in
107citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

107 citing papers in PubMed, 340 citations in OpenAlex.

  1. Article
  2. Article
  3. Redox Regulation of KAntioxidants & redox signaling · 2024
    Review
  4. Review
  5. Review
  6. The CaPharmaceutics · 2022
    Article
  7. Article
  8. Article
  9. Modulation of Lymphocyte Potassium Channel KACS pharmacology & translational science · 2020
    Article
  10. Periodic Membrane Potential and CaInternational journal of molecular sciences · 2020
    Article
  11. Review
  12. CaJournal of immunology (Baltimore, Md. : 1950) · 2018
    Article
  13. Review
  14. GABAAmerican journal of physiology. Lung cellular and molecular physiology · 2017
    Article
  15. Nimodipine fosters remyelination in a mouse model of multiple sclerosis and induces microglia-specific apoptosis.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

47 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

K G Chandy
T E DeCoursey
M D Cahalan
C McLaughlin
S Gupta

Funding

REGULATED GENES IN MUCORALESP01AI016252 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LEHRER, ROBERT IRVING · 1985 to 1988
–
CELLULAR AND MOLECULAR INTERACTIONS IN AGING HUMANSR01AG004361 · NIA · UNIVERSITY OF CALIFORNIA IRVINE · PI GUPTA, SUDHIR · 1985 to 1986
–
AMLR AND LYMPHOID DIFFERENTIATION IN AIDSR01AI020717 · NIAID · UNIVERSITY OF CALIFORNIA IRVINE · PI GUPTA, SUDHIR · 1985 to 1985
–
NIAID NIH HHS AI-16252NIAID NIH HHS AI-20717NIA NIH HHS AG-04361
6 · The paper itself

Abstract

The calcium channel blockers, verapamil and diltiazem, inhibit phytohemagglutinin (PHA)-induced mitogenesis at concentrations that block the T lymphocyte K channel currents. K channel blockers also inhibit the allogeneic mixed lymphocyte response in a dose-dependent manner with the same potency sequence as for block of K currents. K channel blockers inhibit PHA-stimulated mitogenesis only if added during the first 20-30 h after PHA addition, but not later, indicating a requirement for functional K channels during this period. We investigated the effect of K channel blockers on various aspects of protein synthesis for two reasons: first, protein synthesis appears to be necessary for the events leading to DNA synthesis, and second, the increase in the protein synthetic rate commences during the first 24-48 h after PHA addition. PHA-induced total protein synthesis was reduced to the level in unstimulated T lymphocytes by K channel blockers in a dose-dependent manner with the same potency sequence as for the block of K currents and inhibition of [3H]thymidine incorporation. Two-dimensional gel electrophoresis demonstrated that although the synthesis of the majority of proteins was reduced by K channel blockers to the level in unstimulated T cells, some proteins continued to be synthesized at an enhanced rate compared with resting cells. Two proteins, S and T, detected by two-dimensional gel electrophoresis in unstimulated T lymphocytes, appeared to be reduced in intensity in gels of PHA-treated T lymphocytes, in contrast to the increased synthesis of the remaining proteins. 4-Aminopyridine (4-AP), at concentrations that inhibit protein synthesis, prevented the apparent PHA-induced reduction of proteins S and T. These proteins may play a role in maintaining the T lymphocyte in a resting state and may be related to the translation inhibitory factors reported to be present at a higher specific activity in quiescent T lymphocytes than in PHA-activated T cells. The expression of the IL-2 receptor (Tac) during T lymphocyte activation was not altered by K channel blockers, whereas the production of interleukin 2 (IL-2) was reduced to the level in unstimulated T lymphocytes. Exogenous IL-2 partially relieved the inhibition of mitogenesis by low, but not by high, concentrations of 4-AP. These experiments clarify the role of K channels in T lymphocyte activation and suggest that functional K channels are required either for protein synthesis or for events leading to protein synthesis.

Indexed as

Lymphocyte Activation4-AminopyridineAminopyridinesCell LineDiltiazemElectrophoresis, Polyacrylamide GelHumansInterleukin-2Ion ChannelsKineticsLeucineLymphocyte Culture Test, MixedPhytohemagglutininsPotassiumProtein BiosynthesisThymidine4-AminopyridineAminopyridinesDiltiazemInterleukin-2Ion ChannelsLeucinePhytohemagglutininsPotassiumThymidineVerapamil

Identifiers

PMID6088661
PMCPMC2187449
OpenAlexW2125469822

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.